German football league Bundesliga is reportedly planning to start using blood testing this season although it has no indication that doping is a factor in football.
According to Sport24, Bundesliga's plans comes in the wake of a study on doping, which has sparked a debate in Germany on the problem, with calls growing for a federal anti-doping law and to publish the full report, with all the names.
The report further said that FIFA's medical officer at the time is quoted in the study as saying that three players showed 'fine traces' of ephedrine, a banned stimulant, after West Germany lost the 1966 World Cup final to host England.
However, German Football Federation president Wolfgang Niersbach said that the Bundesliga decision was made before the study was published, with German Football League managing director Andreas Rettig saying that the league wants 'stricter controls' although it has 'no indication' of doping.
The report however, said that the tests would not be ready in time for the start of the season this weekend as the federation (DFB) and the National Anti-Doping Agency (NADA) are still working on a contract for the tests, to be conducted by NADA.
Blood testing for banned substances has been used in many major sports for years, the report added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
